V-032

ボリコナゾール 溶液

2.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant^®

• 実験式（ヒル表記法）: C₁₆H₁₄F₃N₅O
• CAS番号: 137234-62-9
• 分子量: 349.31
• UNSPSC Code: 41116107
• NACRES: NA.24

特性

• grade: certified reference material
• Quality Segment: 300
• form: liquid
• feature: (Snap-N-Spike^®)
• packaging: ampule of 1 mL
• manufacturer/tradename: Cerilliant^®
• concentration: 2.0 mg/mL in methanol
• technique(s): gas chromatography (GC): suitable, liquid chromatography (LC): suitable
• application(s): clinical testing
• format: single component solution
• storage temp.: −20°C
• SMILES string: Fc1c(ncnc1)[C@@H]([C@](O)(C[n]3ncnc3)c2c(cc(cc2)F)F)C
• InChI: 1S/C16H14F3N5O/c1-10(15-14(19)5-20-7-22-15)16(25,6-24-9-21-8-23-24)12-3-2-11(17)4-13(12)18/h2-5,7-10,25H,6H2,1H3/t10-,16+/m0/s1
• InChI key: BCEHBSKCWLPMDN-MGPLVRAMSA-N

詳細

General description

Voriconazole, sold under the trade name Vfend^®, is a triazole antifungal drug prescribed for treatment of serious, invasive fungal infections. This certified Snap-N-Spike^® Solution is suitable as starting material for linearity standards, calibrators, or controls for therapeutic drug monitoring or clinical and diagnostic testing of voriconazole in patient blood, serum, or plasma samples by HPLC or LC-MS/MS.

Legal Information

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

Vfend is a registered trademark of Pfizer, Inc.

安全性情報

• pictograms: GHS02,GHS06,GHS08
• signalword: Danger
• hcodes: H225,H301 + H311 + H331,H370
• pcodes: P210 - P233 - P280 - P301 + P310 - P303 + P361 + P353 - P304 + P340 + P311
• Hazard Classifications: Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1
• target_organs: Eyes,Central nervous system
• 保管分類: 3 - Flammable liquids
• wgk: WGK 2
• flash_point_f: 49.5 °F - closed cup
• flash_point_c: 9.7 °C - closed cup